A new study at Moffitt Cancer Center could offer hope to people with melanoma, the deadliest form of skin cancer.
Researchers are investigating whether an injectable known as PV-10 can shrink tumors and reduce the spread of cancer. PV-10 is a solution developed from Rose Bengal, a water-soluble dye commonly used to stain damaged cells in the eye. Early clinical trials show PV-10 can boost immune response in melanoma tumors, as well as the blood stream.
“Various injection therapies for melanoma have been examined over the past 40 years, but few have shown the promising results we are seeing with PV-10,” said Shari Pilon-Thomas, Ph.D., assistant member of Moffitt’sImmunology Program.
In the initial study, researchers injected a single dose of PV-10 into mice with melanoma. The result was a significant reduction in the skin cancer lesions, as well as a sizable reduction in melanoma tumors that had spread to the lungs. The researchers said the dye solution appeared to produce a robust anti-tumor immune response and may be safer than existing immunological agents.
“We are currently in the middle of our first human clinical trial of PV-10 for advanced melanoma patients. In addition to monitoring the response of injected melanoma tumors, we are also measuring the boost in the anti-tumor immune cells of patients after injection,” explained Amod A. Sarnaik, M.D., assistant member of Moffitt’s Cutaneous Oncology Program.
The Latest on: Melanoma
Melanoma researcher selected as NextGen Star by cancer research association
on May 25, 2018 at 3:24 pm
Dr. Willy Hugo, adjunct assistant professor of medicine and dermatology in the David Geffen School of Medicine at UCLA, has been named as a NextGen Star by the American Association of Cancer Research for his efforts in finding new ways to combat melanoma ... […]
Melanoma Awareness Month: Prevention, diagnosis, treatment
on May 25, 2018 at 2:32 am
It's the body's largest and fastest growing organ, but how well do you really know your own skin? May is Melanoma Awareness Month. The deadly cancer is curable if recognized and treated early on. WFMZ's Alexandra Hogan was at LVHN to hear one survivor's ... […]
Global Melanoma Therapeutics Market Growth Opportunities: Galectin Therapeutics, Celgene Corporation
on May 24, 2018 at 9:28 pm
May 25, 2018 (marketresearch.biz via COMTEX) -- The research study “Global Melanoma Therapeutics Industry” provides strategic appraisal of the Melanoma Therapeutics market. Our expedition specialists acutely determine the momentous aspects of the ... […]
A brighter future for melanoma patients through tumor-targeting agents
on May 24, 2018 at 1:00 pm
What he thought was a simple shaving nick on his jawline turned out to be something much more dangerous. When the pimple-sized sore refused to heal, Jim Lemons turned to his doctor, who did a biopsy and discovered it was melanoma, the deadliest type of ... […]
Big Drop in Malignant Melanoma Rate After Bariatric Surgery
on May 24, 2018 at 10:10 am
VIENNA — Obese patients who undergo weight loss surgery appear to experience a substantial reduction in the risk of both skin cancer in general and malignant melanoma in particular, new results from a landmark prospective study indicate. Presenting 18 ... […]
Weight-loss surgery is associated with a reduced risk of melanoma, researchers say
on May 24, 2018 at 12:35 am
In addition to rapid and lasting weight loss and a passel of other health benefits, bariatric surgery has now been linked to a 61% reduction in the risk of developing malignant melanoma, a deadly form of skin cancer most closely associated with excessive ... […]
Melanoma deserves our attention
on May 23, 2018 at 6:43 am
May is national Melanoma/Skin Cancer Detection and Prevention Month. I come from a Montana melanoma family. While one in five Americans typically develop skin cancer over a lifetime, my family is three for six to date. Our farm/ranch work kept us under the ... […]
For high-risk melanoma patients, this Penn app could prove lifesaving
on May 23, 2018 at 2:00 am
Four years ago, Kim Herrity noticed that a dime-sized mole on the back of her leg had turned itchy and black. A subsequent biopsy revealed stage 3 melanoma. Since having the mole removed along with a lymph node in her groin, Herrity, 38, has remained ... […]
Daily aspirin linked to higher melanoma risk for men
on May 21, 2018 at 7:50 am
Men who take once-daily aspirin have nearly double the risk of melanoma compared to men who don’t, according to a new study. Women, however, do not have an increased risk in this large patient population, the study found. “Given the widespread use of ... […]
via Google News and Bing News